AKT1 and neoplasm: Studies have shown that tumor cell proliferation is abrogated by inhibiting LAPTM4B-mediated activation of AKT signaling in addition to disruption of the interaction between LAPTM4B and SH3 domain-containing proteins to control cancer invasion and metastasis [21].